These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30581043)

  • 21. Fingerprint directed scaffold hopping for identification of CCR2 antagonists.
    Nair PC; Sobhia ME
    J Chem Inf Model; 2008 Sep; 48(9):1891-902. PubMed ID: 18763838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural refinement and prediction of potential CCR2 antagonists through validated multi-QSAR modeling studies.
    Amin SA; Adhikari N; Baidya SK; Gayen S; Jha T
    J Biomol Struct Dyn; 2019 Jan; 37(1):75-94. PubMed ID: 29251559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A unique ligand-steered strategy for CC chemokine receptor 2 homology modeling to facilitate structure-based virtual screening.
    Jin H; Xia J; Liu Z; Wang XS; Zhang L
    Chem Biol Drug Des; 2021 Apr; 97(4):944-961. PubMed ID: 33386704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2.
    Huma ZE; Sanchez J; Lim HD; Bridgford JL; Huang C; Parker BJ; Pazhamalil JG; Porebski BT; Pfleger KDG; Lane JR; Canals M; Stone MJ
    Sci Signal; 2017 May; 10(480):. PubMed ID: 28536301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
    Carter PH; Tebben AJ
    Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, binding affinity and structure-activity relationships of novel, selective and dual targeting CCR2 and CCR5 receptor antagonists.
    Junker A; Kokornaczyk AK; Zweemer AJ; Frehland B; Schepmann D; Yamaguchi J; Itami K; Faust A; Hermann S; Wagner S; Schäfers M; Koch M; Weiss C; Heitman LH; Kopka K; Wünsch B
    Org Biomol Chem; 2015 Feb; 13(8):2407-22. PubMed ID: 25566983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 - 2012.
    Carter PH
    Expert Opin Ther Pat; 2013 May; 23(5):549-68. PubMed ID: 23428142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5.
    Ortiz Zacarías NV; van Veldhoven JPD; den Hollander LS; Dogan B; Openy J; Hsiao YY; Lenselink EB; Heitman LH; IJzerman AP
    J Med Chem; 2019 Dec; 62(24):11035-11053. PubMed ID: 31742400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis for the binding of the membrane-proximal C-terminal region of chemokine receptor CCR2 with the cytosolic regulator FROUNT.
    Esaki K; Yoshinaga S; Tsuji T; Toda E; Terashima Y; Saitoh T; Kohda D; Kohno T; Osawa M; Ueda T; Shimada I; Matsushima K; Terasawa H
    FEBS J; 2014 Dec; 281(24):5552-66. PubMed ID: 25283965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7.
    Jaeger K; Bruenle S; Weinert T; Guba W; Muehle J; Miyazaki T; Weber M; Furrer A; Haenggi N; Tetaz T; Huang CY; Mattle D; Vonach JM; Gast A; Kuglstatter A; Rudolph MG; Nogly P; Benz J; Dawson RJP; Standfuss J
    Cell; 2019 Aug; 178(5):1222-1230.e10. PubMed ID: 31442409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
    Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a binding element for the cytoplasmic regulator FROUNT in the membrane-proximal C-terminal region of chemokine receptors CCR2 and CCR5.
    Toda E; Terashima Y; Esaki K; Yoshinaga S; Sugihara M; Kofuku Y; Shimada I; Suwa M; Kanegasaki S; Terasawa H; Matsushima K
    Biochem J; 2014 Jan; 457(2):313-22. PubMed ID: 24128342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of CCR2-binding features in Cytl1 by a CCL2-like chemokine model.
    Tomczak A; Pisabarro MT
    Proteins; 2011 Apr; 79(4):1277-92. PubMed ID: 21322034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure modeling of the chemokine receptor CCR5: implications for ligand binding and selectivity.
    Paterlini MG
    Biophys J; 2002 Dec; 83(6):3012-31. PubMed ID: 12496074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of novel small molecule CCR2 antagonists: evaluation of 4-aminopiperidine derivatives.
    Vilums M; Zweemer AJ; Dekkers S; Askar Y; de Vries H; Saunders J; Stamos D; Brussee J; Heitman LH; IJzerman AP
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5377-80. PubMed ID: 25453791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QSAR studies on CCR2 antagonists with chiral sensitive hologram descriptors.
    Nair PC; Srikanth K; Sobhia ME
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1323-30. PubMed ID: 18258426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists.
    Cherney RJ; Mo R; Meyer DT; Nelson DJ; Lo YC; Yang G; Scherle PA; Mandlekar S; Wasserman ZR; Jezak H; Solomon KA; Tebben AJ; Carter PH; Decicco CP
    J Med Chem; 2008 Feb; 51(4):721-4. PubMed ID: 18232650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrido[4,3-c]azepin-5-one-based novel chemotype CCR2 antagonists via scaffold hopping strategy.
    Qin LH; Wang ZL; Xie X; Long YQ
    Bioorg Med Chem; 2018 Jul; 26(12):3559-3572. PubMed ID: 29805075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, structure-activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonists.
    Xia M; Hou C; DeMong DE; Pollack SR; Pan M; Brackley JA; Jain N; Gerchak C; Singer M; Malaviya R; Matheis M; Olini G; Cavender D; Wachter M
    J Med Chem; 2007 Nov; 50(23):5561-3. PubMed ID: 17929797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Mo R; Meyer DT; Pechulis AD; Guaciaro MA; Lo YC; Yang G; Miller PB; Scherle PA; Zhao Q; Cvijic ME; Barrish JC; Decicco CP; Carter PH
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6181-4. PubMed ID: 22939233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.